Hefei TG ImmunoPharma Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Hefei TG ImmunoPharma Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors (NCT07376707) | Hefei TG ImmunoPharma Co., Ltd. | 2025-06-12 |
| A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors (NCT06374173) | Hefei TG ImmunoPharma Co., Ltd. | 2024-01-03 |
| A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors (NCT05746897) | Hefei TG ImmunoPharma Co., Ltd. | 2023-04-13 |
Track Hefei TG ImmunoPharma Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.